Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 16, 2021. Long positions only.
- Positions
- 25
- No filing for Q2 2021
- Portfolio value
- $1.14B
- No filing for Q2 2021
Johnson & Johnson did not file a 13F for Q2 2021, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CALCCalciMedica, Inc. | COM SHS | 49,547 | $164.0K | <0.1% | – | – | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $185.0K | <0.1% | – | – | History |
| LUNGPulmonx Corp | COM | 5,639 | $203.0K | <0.1% | – | – | History |
| ZYZymergen Inc. | COM | 16,553 | $218.0K | <0.1% | – | – | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 66,951 | $275.0K | <0.1% | – | – | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 84,003 | $325.0K | <0.1% | – | – | History |
| NPCENeuroPace Inc | COM | 55,435 | $879.0K | 0.1% | – | – | History |
| CSLTCastlight Health, Inc. | CL B | 811,295 | $1.27M | 0.1% | – | – | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 394,834 | $3.47M | 0.3% | – | – | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 281,052 | $3.48M | 0.3% | – | – | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 1,607,044 | $5.00M | 0.4% | – | – | History |
| ACETAdicet Bio, Inc. | COM | 728,944 | $5.71M | 0.5% | – | – | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,133,402 | $6.53M | 0.6% | – | – | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,000,000 | $7.69M | 0.7% | – | – | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $16.9M | 1.5% | – | – | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,670,516 | $29.1M | 2.6% | – | – | History |
| MGTXMeiraGTx Holdings plc | COM | 2,898,550 | $38.2M | 3.4% | – | – | History |
| PRCTPROCEPT BioRobotics Corp | COM | 1,018,478 | $38.9M | 3.4% | – | – | History |
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $43.4M | 3.8% | – | – | History |
| CVRXCVRx, Inc. | COM | 3,495,575 | $57.8M | 5.1% | – | – | History |
| HLTHCue Health Inc. | COM | 5,548,864 | $65.5M | 5.7% | – | – | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,629,173 | $82.4M | 7.2% | – | – | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $200.3M | 17.6% | – | – | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 3,260,869 | $203.6M | 17.9% | – | – | History |
| ILMNIllumina, Inc. | COM | 810,170 | $328.6M | 28.8% | – | – | History |